Dae Lee

Popular Topics

Food, Drugs, Healthcare, Life Sciences Employment and HR Accounting and Audit Government, Public Sector Media, Telecoms, IT, Entertainment

Dae Lee’s articles from Buchanan Ingersoll & Rooney PC are most popular:

with readers working within the Healthcare industries
within Finance and Banking, Government, Public Sector, Media, Telecoms, IT and Entertainment topic(s)
in South America, North America and United States

DETAILS

United States

+1 609 9876800

RANKINGS

author rankings top 20% image

This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States

AUTHORS CONTENT

Buchanan Attorneys Reduce PBM Audit Findings By More Than 98%

United States Litigation

Ohio Board Of Pharmacy Proposes Strengthened Disciplinary Actions: What Pharmacies Need To Know

United States Healthcare

Nevada’s Proposed New Regulations: What Pharmacies Need To Know

United States Healthcare

Legacy PBMs Are Siphoning Money From Government Programs. Self Funded Employers Should Assume They Are Next

United States Insurance

DOJ’s 2026 Health Care Fraud Takedown: Why Pharmacies Should Act Before An Audit Becomes An Investigation

United States Criminal

Rhode Island Joins The PBM Oversight Movement: What Senate Bill 3060 Means For Pharmacies, Health Plans And PBM Regulation

United States Healthcare

Arizona Joins The Growing Movement To Separate PBMs From Pharmacy Ownership

United States Government

Cassidy’s 340B Reform Discussion Draft Signals A Shift In The Future Of The 340B Program

United States Healthcare

West Virginia Board Of Pharmacy Adopts New Inspection Rule: What Pharmacies Need To Know Before July 1, 2026

United States Consumer

Florida Takes Aim At CVS Caremark: Why The Sunshine State’s Investigation Could Be A Turning Point For PBM Oversight

United States Media & IT

Maryland Expands Prescriber–Pharmacist Agreements And Opens New Opportunities For Opioid Use Disorder Treatment

United States Healthcare

Tennessee’s FAIR Rx Act Litigation: Why Independent Pharmacies Should Watch This PBM Fight Closely

United States Employment

Eli Lilly’s 340B Claims-Data Policy: What Covered Entities Need To Know

United States Healthcare

Prior Authorization By A Third Party: What Pharmacies Need To Know Before The PBM Audit Comes

United States Healthcare

CMS Signals The Next Major Phase Of PBM Reform: Why Pharmacies And Plan Sponsors Should Pay Attention Now

United States Healthcare

HRSA’s 340B Rebate Model Is Moving Faster Than Many Expected: What Covered Entities Should Be Doing Now

United States Healthcare

Express Scripts Challenges Tennessee Fair Rx Act: Another Attempt To Preserve The Status Quo

United States Healthcare

Federal And State Program-Integrity Scrutiny Of Pharmacies Is Increasing: What Pharmacies Need To Know

United States Government

Pharmacy Change Of Ownership Transactions: Why CHOW Must Be Handled Correctly

United States Healthcare

The No Surprises Act Is Becoming A Legal And Reimbursement Trap For Providers

United States Healthcare

AWARDS

Spring 2025 Award for Food, Drugs, Healthcare, Life Sciences in United States

Food, Drugs, Healthcare, Life Sciences

FDA's Removal Of Semaglutide And The Evolving Tirzepatide Decisions: What Compounders Need To Know

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More